未登录.png)
分享.png)
收藏Albumin-Bilirubin Grade Analyses of Atezolizumab Plus Bevacizumab vs Sorafenib in Patients With Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study不可切除肝细胞癌患者中阿特珠单抗联合贝伐单抗与索拉非尼的白蛋白-胆红素等级分析: IMbrave150 III期研究的事后分析
Kudo, Masatoshi; Finn, Richard S.; Cheng, Ann-Lii; Zhu, Andrew X.; Ducreux, Michel; Galle, Peter R.; Sakamoto, Naoya; Kato, Naoya; Nakano, Michitaka; Jia, Jing; Vogel, Arndt 分享 收藏 LncRNA DANCR Enhances Angiogenesis to Promote Melanoma Via miR-5194Jia, Jing; Zhu, Xinxi; Xue, Kaihua; Huang, Yuanmei; Wu, Menglu; Yang, Yanan; Liu, Wenbo; Zhang, Hongke; He, Lin; Sun, Hong 分享 收藏 IMbrave150: Efficacy and Safety of Atezolizumab Plus Bevacizumab vs Sorafenib in Patients With Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma-An Exploratory Analysis of the Phase III StudyIMbrave150: 阿特珠单抗联合贝伐单抗与索拉非尼在巴塞罗那临床肝癌B期不可切除肝细胞癌患者中的疗效和安全性-III期研究的探索性分析Kudo, Masatoshi; Finn, Richard S. S.; Galle, Peter R. R.; Zhu, Andrew X. X.; Ducreux, Michel; Cheng, Ann-Lii; Ikeda, Masafumi; Tsuchiya, Kaoru; Aoki, Ken-ichi; Jia, Jing; Lencioni, Riccardo 分享 收藏 分享 收藏 A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung AdenocarcinomaWang, Xuewen; Zhao, Chengfei; Huang, Dandan; Liu, Zhoujie; Liu, Mengmeng; Lin, Fei; Lu, Yingyu; Jia, Jing; Lin, Liqing; Lin, Xinhua; Li, Huangyuan; Chen, Zhiwei 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
LIVER CANCER.png)
OAAI